mynth
← DATABASE
07/2019

ALERIS acquired by TRITON PARTNERS

SWEDEN Health Providers / Healthcare Facilities / Clinics / Hospitals EV SEK 1–10bn

Context

Triton Partners acquired a controlling majority stake in Aleris Group from Patricia Industries in a significant Nordic healthcare transaction. The deal was structured via a definitive share purchase agreement and funded primarily through equity drawn from the Triton Fund V, a flagship vehicle that finalized fundraising at €5 billion in January 2019. Under the binding terms of the carve-out agreement, the digital healthcare platform entity Doktor24 was explicitly excluded from the perimeter and remained under the ownership of Patricia Industries. The transaction immediately transitioned Aleris into Triton’s healthcare portfolio, providing the asset with substantial institutional backing and capital reserves to fund downstream digital infrastructure updates and target localized clinical bolt-on acquisitions.

ALERIS, which reported an EBITDA margin of [members only] in 2019, is valued in this transaction at an EV/EBITDA multiple of 15x–25x, representing a premium to the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Aleris Group is a premier Scandinavian healthcare provider specializing in high-quality elective surgery, outpatient mental health services, and medical diagnostics. Headquartered in Stockholm, Sweden, the company operates via a multi-payer economic model, serving roughly millions patient visits annually through public healthcare system allocations, private health insurance programs, and out-of-pocket direct payments. The organization runs a unified network of approximately +100 clinics and hospitals staffed by +5,000 specialized medical professionals across Sweden, Norway, and Denmark. Strategically, the firm acts as a dominant, high-equity clinical complement to publicly funded healthcare systems, utilizing advanced digital infrastructure to streamline outpatient care pathways.

Ent. Value

SEK 1–10bn

Equity Value

[members only]

Multiples

EV / Revenue

below 1.5x

EV / EBITDA

15x–25x

EV / EBIT

[members only]

Historical Financials (SEK)

Year
Rev
EBITDA
EBIT
2019
SEK 1–10bn
SEK 100–200M
[members only]
2018
SEK 1–10bn
SEK 100–200M
[members only]

Other operations with ALERIS

Other operations with ALERIS

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
DateAcquirerTargetCountrySector
05/2026MEHILÄINEN GROUPALERISSWEDENClinics / Hospitals

REFERENCES

Valuation range: EV SEK 1–10bn

Revenue range: SEK 1–10bn

EBITDA range: SEK 100–200M

EV/Revenue range: below 1.5x

EV/EBITDA range: 15x - 25x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ALERIS by TRITON PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: triton partners